Low adiponectin levels have been highlighted as having a significant impact on obesity occurrence, type 2 diabetes development and cardiovascular diseases raise, probably due to the adiponectin related insulin resistance and inflammation [57, 58]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.